EPSMomentum

$ARWR with a neutral outlook following its earning release

NASDAQ:ARWR   Arrowhead Pharmaceuticals, Inc.
$ARWR released its earnings with a negative under reaction following its announcement with the PEAD projecting a neutral outlook and placing the stock in Drift D

If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.


Professional grade tools including Earning momentum and Post earning announcement drift price forecast. www.epsmomentum.com
면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.